The basic principle for definition of the term "Fine Chemicals" is a three-tier segmentation of the universe of chemicals into commodities, fine chemicals, and specialty chemicals
Fine chemicals are complex, single, pure chemical substances. They are produced in limited quantities (<1000 metric tons per year) in multipurpose plants by multistep batch chemical or biotech(nological) processes.
The category is further sub-divided on the basis of either the added value (building blocks, advanced intermediates, or active ingredients) or the type of business transaction (standard or exclusive products).
According Zion Market Research report, Global pharmaceutical intermediates market was valued at approximately USD 25,440 million in 2017 and is expected to generate revenue of around USD 33,608 million by end of 2024, growing at a CAGR of around 4.0% between 2018 and 2024.
Pharmaceutical intermediates are chemical compounds which form the building blocks of the active pharmaceutical ingredient (API).
Pharmaceutical intermediates are produced as a by-product during the production of API. Every reaction in the production process of API gives rise to various different pharmaceutical intermediates. Pharmaceutical intermediates are used in the production of bulk drugs and also for research and development purpose by various pharma and biopharma companies.
The pharmaceutical industry is ever thirsty to satisfy patient’s therapeutically needs and apart from active ingredients, inactive excipients play a major role in formulation development. Pharmaceutical excipients are substances other than the pharmacologically active drug or prodrug which are included in the manufacturing process or are contained in a finished
pharmaceutical product dosage form.
Fine Chemicals, Intermediaries and Excipient sectors:
- Blenders
- Emulsifiers
- Homogenizers
Last year`s exhibitors from this sector: 12%
